Evaluation of Local Capillary Blood Lactate in Chronic Critical Ischemia of Lower Limb Before and After Revascularization

Evaluation of Local Capillary Blood Lactate in Chronic Critical Ischemia of Lower Limb Before and After Revascularization.

Status

Terminated

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01634815

Acronym

ELIT

Enrollment

Registered

2012-07-06

Start date

2013-02-04

Completion date

2015-08-21

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Critical Ischemia

Brief summary

Evaluation of a new biological criterion, the local capillary blood lactates to optimize the management of patients with chronic critical ischemia requiring revascularization fast. Potential use in terms of capillary blood lactate as a diagnostic indicator of recurrent ischemia in a limb revascularized.

Interventions

PROCEDUREThe Edge

measuring blood lactate

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

DIAGNOSTIC

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Ischemia Chronic critical lower limb revascularization procedure requiring fast. * Written consent informed patient age greater than or equal to 18

Exclusion criteria

* Presence of an inflammatory or infectious (erysipelas) in the ischemic member. * Patients at risk for diabetic foot ie, as defined by the HAS (preventing diabetic foot, 2007) * presence of sensory neuropathy, and / or * foot deformities (hallux valgus, hammer toes or claw, prominence of the metatarsal heads), and / or * history of foot ulceration, and / or * antecedent of one of these factors (ie antécedant diabetic foot). * Necrosis of the toes. * Participation in another clinical research protocol. * Presence of peripheral arterial disease in the bilateral upper limbs. * Patient in shock whatever the cause. * Presence of hepatic failure. * Too impaired general condition (bedridden, dementia, ...) * Refusal of the patient to participate in the study * Protected patients

Design outcomes

Primary

Measure	Time frame	Description
Report Capillary blood lactate To Finger Capillary blood lactate (LCO / LCD)	48 hours	Report Capillary blood lactate To Finger Capillary blood lactate (LCO / LCD) before revascularization of the lower limb in chronic critical limb ischemia (considered positive if\> 2).

Secondary

Measure	Time frame	Description
The decrease in the ratio LCO/LCD	48 hours	The decrease in the ratio LCO / LCD in the immediate aftermath of revascularization

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026